<  Retour au portail Polytechnique Montréal

Cerebrospinal Fluid Biomarkers, Brain Structural and Cognitive Performances Between Normotensive and Hypertensive Controlled, Uncontrolled and Untreated 70-Year-Old Adults

Atef Badji, Joana B. Pereira, Sara Shams, Johan Skoog, Anna Marseglia, Konstantinos Poulakis, Lina Rydén, Kaj Blennow, Henrik Zetterberg, Silke Kern, Anna Zettergren, Lars-Olof Wahlund, Hélène Girouard, Ingmar Skoog et Eric Westman

Article de revue (2022)

Document en libre accès dans PolyPublie et chez l'éditeur officiel
[img]
Affichage préliminaire
Libre accès au plein texte de ce document
Version officielle de l'éditeur
Conditions d'utilisation: Creative Commons: Attribution (CC BY)
Télécharger (375kB)
Afficher le résumé
Cacher le résumé

Abstract

Background: Hypertension is an important risk factor for Alzheimer’s disease (AD). The pathophysiological mechanisms underlying the relationship between AD and hypertension are not fully understood, but they most likely involve microvascular dysfunction and cerebrovascular pathology. Although previous studies have assessed the impact of hypertension on different markers of brain integrity, no study has yet provided a comprehensive comparison of cerebrospinal fluid (CSF) biomarkers and structural brain differences between normotensive and hypertensive groups in a single and large cohort of older adults in relationship to cognitive performances.

Objective: The aim of the present work was to investigate the differences in cognitive performances, CSF biomarkers and magnetic resonance imaging (MRI) of brain structure between normotensive, controlled hypertensive, uncontrolled hypertensive, and untreated hypertensive older adults from the Gothenburg H70 Birth Cohort Studies.

Methods: As an indicator of vascular brain pathology, we measured white matter hyperintensities (WMHs), lacunes, cerebral microbleeds, enlarged perivascular space (epvs), and fractional anisotropy (FA). To assess markers of AD pathology/neurodegeneration, we measured hippocampal volume, temporal cortical thickness on MRI, and amyloid-β42, phosphorylated tau, and neurofilament light protein (NfL) in cerebrospinal fluid. Various neuropsychological tests were used to assess performances in memory, attention/processing speed, executive function, verbal fluency, and visuospatial abilities.

Results: We found more white matter pathology in hypertensive compared to normotensive participants, with the highest vascular burden in uncontrolled participants (e.g., lower FA, more WMHs, and epvs). No significant difference was found in any MRI or CSF markers of AD pathology/neurodegeneration when comparing normotensive and hypertensive participants, nor among hypertensive groups. No significant difference was found in most cognitive functions between groups.

Conclusion: Our results suggest that good blood pressure control may help prevent cerebrovascular pathology. In addition, hypertension may contribute to cognitive decline through its effect on cerebrovascular pathology rather than AD-related pathology. These findings suggest that hypertension is associated with MRI markers of vascular pathology in the absence of a significant decline in cognitive functions.

Mots clés

CSF (cerebrospinal fluid); hypertension; brain; MRI; white matter; aging.

Renseignements supplémentaires: The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fnagi.2021.777475/full#supplementary-material
Sujet(s): 1900 Génie biomédical > 1900 Génie biomédical
Département: Institut de génie biomédical
Centre de recherche: NeuroPoly - Laboratoire de Recherche en Neuroimagerie
Organismes subventionnaires: TransMedTech, Mitacs Globalink, Québec Bio-Imaging Network, Swedish Research Council, European Research Council, Swedish State Support for Clinical Research, Alzheimer Drug Discovery Foundation (ADDF), United States, European Union’s Horizon 2020 Research and Innovation Program under the Marie Skłodowska-Curie grant, UK Dementia Research Institute at UCL, Swedish Research Council, Swedish Alzheimer Foundation, Hjärnfonden, Sweden, Swedish state under the agreement between the Swedish government and the County Councils, the ALF-agreement, Swedish Research Council for Health, Working Life and Welfare, Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse, Hjärnfonden, Alzheimerfonden, Eivind och Elsa K:son Sylvans stiftelse
Numéro de subvention: 2018-02532, 681712, ALFGBG-72093, 201809-2016862, 860197, 2017-00915, AF-742881, FO2017-0243, ALFGBG-715986, ALF 716681, 2012-5041, 2015-02830, 2019-01096, 2013-8717, 2017-00639, 2013-1202, 2018-00471, AGECAP 2013-2300, 2013-2496, FO2014-0207, FO2016- 0214, FO2018-0214, FO2019-0163, FO2020-0235, AF-554461, AF-647651, AF-743701, AF- 84467, AF-93086, AF-94013
URL de PolyPublie: https://publications.polymtl.ca/50250/
Titre de la revue: Frontiers in Aging Neuroscience (vol. 13)
Maison d'édition: Frontiers Media
DOI: 10.3389/fnagi.2021.777475
URL officielle: https://doi.org/10.3389/fnagi.2021.777475
Date du dépôt: 18 avr. 2023 14:58
Dernière modification: 01 oct. 2024 13:57
Citer en APA 7: Badji, A., Pereira, J. B., Shams, S., Skoog, J., Marseglia, A., Poulakis, K., Rydén, L., Blennow, K., Zetterberg, H., Kern, S., Zettergren, A., Wahlund, L.-O., Girouard, H., Skoog, I., & Westman, E. (2022). Cerebrospinal Fluid Biomarkers, Brain Structural and Cognitive Performances Between Normotensive and Hypertensive Controlled, Uncontrolled and Untreated 70-Year-Old Adults. Frontiers in Aging Neuroscience, 13, 777475 (14 pages). https://doi.org/10.3389/fnagi.2021.777475

Statistiques

Total des téléchargements à partir de PolyPublie

Téléchargements par année

Provenance des téléchargements

Dimensions

Actions réservées au personnel

Afficher document Afficher document